Respiratory Pharmacology, Pharmacology and Toxicology Section, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, Exhibition Road, London, SW7 2AZ, UK.
Lung. 2010 Jan;188 Suppl 1:S9-12. doi: 10.1007/s00408-009-9190-2. Epub 2009 Oct 15.
Prostanoids such as prostaglandin (PG) D(2), PGE(2), PGF(2alpha), prostacyclin (PGI(2)), and thromboxane (Tx) A(2) act via five classes of receptors named DP, EP, FP, IP, and TP, respectively, and mediate a diverse range of physiological effects. Prostanoids are commonly associated with many diseases as a proinflammatory mediator; however, in the lung, prostanoids, particularly PGE(2), seem to have a protective role. Inhaled PGE(2) has been shown to be anti-inflammatory and a bronchodilator but causes cough. This has hindered the development of prostanoids for the treatment of airway inflammatory diseases. We discuss here the extensive research into the role of prostanoids in the airways and their modulation of the cough reflex.
前列腺素类物质(如前列腺素 D(PGD)(2)、前列腺素 E(PGE)(2)、前列腺素 F(PGF)(2alpha)、前列环素(PGI)(2)和血栓素 A(Tx)(2))通过分别命名的 DP、EP、FP、IP 和 TP 五种类别受体起作用,并介导广泛的生理效应。前列腺素类物质通常作为促炎介质与许多疾病相关;然而,在肺部,前列腺素类物质,特别是 PGE(2),似乎具有保护作用。已经表明吸入 PGE(2)具有抗炎和支气管扩张作用,但会引起咳嗽。这阻碍了前列腺素类物质在气道炎症性疾病治疗中的发展。我们在这里讨论了前列腺素类物质在气道中的广泛研究及其对咳嗽反射的调节。